Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV

被引：1
|
作者：
Cossu, Maria Vittoria [1 ]
D'Avolio, Antonio [2 ]
Gervasoni, Cristina [1 ]
Giacomelli, Andrea [1 ]
Cattaneo, Dario [1 ]
Moschese, Davide [1 ]
机构：
[1] ASST Fatebenefratelli Sacco Univ Hosp, Dept Infect Dis, Milan, Italy
[2] Univ Turin, Amedeo Savoia Hosp, Dept Med Sci, Lab Clin Pharmacol & Pharmacogenet, Turin, Italy
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2024年 / 68卷 / 05期
关键词：
human immunodeficiency virus; PHARMACOKINETICS; TOLERABILITY; GSK1265744; ADULTS; SAFETY;
D O I：
10.1128/aac.00175-24
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reply to Cossu et al., "Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV"
    Han, Kelong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (05)
  • [2] Intramuscular cabotegravir and rilpivirine concentrations after switching from efavirenz-containing regimen
    Bettonte, Sara
    Berton, Mattia
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (12) : 3618 - 3628
  • [3] Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine
    Rubenstein, Emma
    Diemer, Myriam
    Goldwirt, Lauriane
    Lascoux-Combe, Caroline
    Chaix, Marie-Laure
    Rami, Agathe
    Ponscarme, Diane
    Lafaurie, Matthieu
    Denis, Blandine
    De Castro, Nathalie
    Gras, Julien
    Liegeon, Geoffroy
    Sellier, Pierre-Olivier
    Deville, Laure
    Chevret, Sylvie
    Delaugerre, Constance
    Molina, Jean-Michel
    AIDS, 2024, 38 (08) : 1267 - 1269
  • [4] Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals
    Cossu, Maria Vittoria
    Cattaneo, Dario
    Moschese, Davide
    Giacomelli, Andrea
    Soloperto, Sara
    D'Avolio, Antonio
    Antinori, Spinello
    Gori, Andrea
    Rizzardini, Giuliano
    Gervasoni, Cristina
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (05) : 1126 - 1132
  • [5] Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 infection switching to long-acting cabotegravir and rilpivirine
    Rubenstein, E.
    Diemer, M.
    Goldwirt, L.
    Lascoux-Combe, C.
    Lafaurie, M.
    Ponscarme, D.
    Denis, B.
    De Castro, N.
    Rami, A.
    Sellier, P. -O.
    Deville, L.
    Chaix, M. -L.
    Delaugerre, C.
    Molina, J. -M.
    HIV MEDICINE, 2023, 24 : 481 - 482
  • [6] Cabotegravir and rilpivirine concentrations and HIV-1 RNA suppression in male and female genital fluids and rectal tissue in people with HIV on antiretroviral therapy with long-acting intramuscular cabotegravir plus rilpivirine
    Fernandez, Analuz
    Scevola, Sofia
    Niubo, Jordi
    Sykes, Craig
    Schauer, Amanda P.
    Piatti, Camila
    Morenilla, Sandra
    Sedo, Alicia
    Soriano, Irene
    Garcia, Benito
    Medina, Daniel
    Tiraboschi, Juan
    Saumoy, Maria
    Cottrell, Mackenzie L.
    Imaz, Arkaitz
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 3 - 4
  • [7] Transforming HIV care: intramuscular bimonthly cabotegravir and rilpivirine for transgender people with HIV in Spain (RELATIVITY cohort)
    de Santiago, Alberto Diaz
    Ryan-Murua, Pablo
    Crusells-Canales, Maria Jose
    Buzon Martin, Luis
    Martin-Rico, Patricia
    Bisbal-Pardo, Otilia
    Arenas-Garcia, Victor
    Cabello-Ubeda, Alfonso
    Egido-Murciano, Miguel
    Pedrero-Tome, Roberto
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 181 - 182
  • [8] Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV
    Mazzitelli, Maria
    Agostini, Elena
    Vania, Eleonora
    Presa, Nicolo
    Sasset, Lolita
    Leoni, Davide
    Gardin, Samuele
    Scaglione, Vincenzo
    Cattelan, Annamaria
    HIV RESEARCH & CLINICAL PRACTICE, 2024, 25 (01)
  • [9] Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV
    Mazzitelli, M.
    Agostini, E.
    Rossetto, A.
    Vania, E.
    Sasset, L.
    Leoni, D.
    Gardin, S.
    Scaglione, V.
    Cattelan, A.
    HIV MEDICINE, 2023, 24 : 83 - 84
  • [10] Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
    Castelli, Alessandro
    Lanzafame, Massimiliano
    Morra, Matteo
    Bertoldi, Marco
    Delama, Andrea
    Fait, Daniela
    Vento, Sandro
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (05) : 283 - 285
12345